Determinants of mortality in systemic sclerosis: a focused review

• Published in: Rheumatology international Vol. 38; no. 10; pp. 1847 - 1858
• Main Authors: Poudel, Dilli Ram, Jayakumar, Divya, Danve, Abhijeet, Sehra, Shiv Tej, Derk, Chris T.
• Format: Journal Article
• Language: English
• Published: Berlin/Heidelberg Springer Berlin Heidelberg 01-10-2018; Springer Nature B.V
• Subjects: Fibrosis; Humans; Medicine; Medicine & Public Health; Morbidity - trends; Mortality; Observational Research; Population; Rheumatology; Scleroderma; Scleroderma, Localized - mortality; Scleroderma, Systemic - complications; Scleroderma, Systemic - mortality; Systemic sclerosis; Review; Scleroderma; Predictor; Survival; Mortality; Systemic sclerosis
• ISSN: 0172-8172; 1437-160X
• DOI: 10.1007/s00296-017-3826-y

Scleroderma (systemic sclerosis) is an autoimmune rheumatic disorder that is characterized by fibrosis, vascular dysfunction, and autoantibody production that involves most visceral organs. It is characterized by a high morbidity and mortality rate, mainly due to disease-related complications. Epidemiological data describing mortality and survival in this population have been based on both population and observational studies. Multiple clinical and non-clinical factors have been found to predict higher likelihood of death among thepatients. Here, we do an extensive review of the available literature, utilizing the PubMed database, to describe scleroderma and non-scleroderma related determinants of mortality in this population. We found that even though the mortality among the general population has declined, scleroderma continues to carry a very high morbidity and mortality rate, however we have made some slow progress in improving the mortality among scleroderma patients over the last few decades.